Status:
UNKNOWN
Platelet Rich Plasma in Corneal Surface Diseases
Lead Sponsor:
Assiut University
Conditions:
Persistent Corneal Epithelial Defects
Dry Eye
Eligibility:
All Genders
18-99 years
Phase:
PHASE3
Brief Summary
The Aim of the study is to evaluate the efficacy of platelet rich plasma eye drops in the management of different corneal surface disorders. PRP is a blood sample with a concentrated platelet count, ...
Detailed Description
There are many conditions in which the ocular surface is severely affected as keratoconjunctivitis sicca, persistent epithelial corneal defect, recurrent corneal erosion, neurotrophic keratopathy, pos...
Eligibility Criteria
Inclusion
- Persistent epithelial defects (Exposure keratopathy, Post infectious keratitis).
- Dry eye disease.
Exclusion
- Active ocular infection or inflammation.
- Patients will be withdrawn if allergic or adverse side effects develop.
- Pregnancy or breast feeding.
- The use of systemic antiplatelet or anticoagulant.
- Uncontrolled systemic diseases
- Non-compliance with the study protocol.
- Positive HIV, HBV, HCB or Syphilis.
- Anemia (less than 10 g/dl of HGB, platelet count less than 105/ul).
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05320172
Start Date
June 1 2023
End Date
June 1 2024
Last Update
February 27 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.